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1. Summary 
Over the next decade the Irish agri-food industry will have to compete in a rapidly changing 
world environment arising from increased competitiveness, decreased world market prices 
and increased consumer demands for higher quality, healthier and safer food. To become 
competitive in this environment the scale and efficiency of production at both farm and 
factory level will have to increase significantly and this must be achieved with due regard for 
the protection of the environment and the welfare of animals. New technologies will be 
needed to achieve this. Biotechnology will be central to the development of these new 
technologies. 
This project has been concerned with the identification and evaluation of biotechnology 
developments that have the potential to increase reproductive efficiency in cattle. This 
includes a range of technologies relating to the in vitro production, manipulation, 
cryopreservation and transfer of cattle embryos. The potential of other emerging 
technologies such as embryo and sperm sexing, cloning and biopharming or the production 
of commercially desirable proteins in cows milk are also addressed in this report. 
2. Introduction 
Biotechnology is currently being hailed as the "new" science or high technology driver of the 
pharmaceutical, medical and agri-food industries. In reality, however, biotechnology has 
been with us for many centuries, millennia even. Broadly defined it is the application of 
technology in the production or modification of products or processes or living organisms in 
order to produce new products or processes. Bacteria, for example, have long been 
genetically manipulated for use in the fermentation process for the brewing, bread and 
cheese making industries. Animal and plant breeders have introduced new genes into 
livestock and crops by a continuous process of selection and cross breeding. Biotechnology 
is not new. What is new, however, is the technology that scientists are now using to modify 
products and the precision with which this can be achieved. It is not that biotechnology has 
suddenly changed, it is that new tools such as automated DNA sequencing together with 
proteomics and bioinformatics are resulting in an explosion of knowledge and understanding 
of the mechanisms by which biological processes occur. It is now widely accepted that 
biotechnology will be one of the most significant technologies of the next 50 years or so and, 
the prediction is, that it has the potential to generate more knowledge over that period than 
all other current technologies combined. 
The importance of biotechnology to the agri-food industry cannot be overestimated. It has 
potential to impact on production and processing technologies not only to increase efficiency 
but to also meet consumer demand for food safety and quality while at the same time 
ensuring the protection of the environment and its sustainability. One area of the overall agri-
food industry that has benefited enormously over the past 50 years from the application of 
biotechnology is animal reproduction. Indeed the application of biotechnology to animal 
reproduction has in itself furthered our understanding of the reproduction process. Some of 
the relevant biotechnologies harnessed to increase the efficiency of cattle reproduction are 
described. 
3. Artificial insemination 
Reproductive biotechnology has been a feature of animal breeding for hundreds of years. 
For example, cattle were domesticated, their reproduction was controlled and they were then 
selected for increased milk production. This enabled the diversion of milk, which is part of 
the reproductive process in mammals, to human use and in turn led to large industries 
producing butter, cheese and a variety of related products. The development and application 
of artificial insemination (AI) in cattle breeding is a powerful and successful example of 
reproduction biotechnology that has revolutionised the breeding of cattle, particularly dairy 
cattle. The use of AI in cattle has allowed the introduction of highly successful genetic 
improvement programs for increasing milk yield and has reduced the incidence of disease. 
With the expansion of the AI industry came developments such as the ability to freeze-store 
or cryopreserve sperm. Indeed the extensive programmes in the cryopreservation of 
biological tissue in the medical world today are largely due to the pioneering work carried out 
on the cryopreservation of cattle sperm about 50 years ago. 
Continuous attempts to expand and increase the efficiency of the AI industry have 
concentrated on a range of aspects including reducing sperm number per insemination, and 
insemination technique and timing. 
4. Oestrus detection 
Oestrus or heat detection is one of the most important tasks in the dairy and beef herds. 
However, it is also one of the most time consuming, subjective and inefficient tasks. An 
objective method of heat detection would be of enormous benefit in increasing output 
efficiency and reducing the time and labour input. A number of possible approaches to 
automate oestrus detection are described. 
Milk Constituent Approach: In the dairy industry herd numbers are increasing, at the same 
time, the availability of farm labour is decreasing. Because of the increased time pressure on 
available farm labour, and consequently, the insufficient time available for successful visual 
checking, a largely unattended or automated approach to heat detection would have huge 
advantages. The onset of heat coincides with significant hormonal changes likely to alter the 
protein composition of milk. Such alterations could be used to identify oestrus-specific 
proteins by comparing the protein profile of milk samples taken at different stages of the 
oestrous cycle. An alternative and more sensitive approach to that of examining the protein 
composition is to examine the expression pattern of the genes that encode these proteins. 
This approach was identified and was the subject of a research project carried out in 
collaboration with the National Diagnostic Centre, NUI, Galway. Molecular biology 
techniques, including differential display reverse transcriptase polymerase chain reaction 
(DDRT-PCR) was used to examine differences in gene expression in mammary tissue taken 
from cows at different stages of the oestrous cycle. A number of novel gene sequences 
found to be present only at oestrus were identified in this way. The identity of these 
sequences were determined but did not show similarity to any previously reported gene 
sequence. They could, however, represent expressed sequences not previously reported. 
Further analysis using a technique called Northern blotting did not confirm expression of 
these sequences in any of the represented stages. This was probably due to those novel 
genes being expressed at a level too low to allow confirmation by Northern analysis at its 
current sensitivity. It is likely that the development of more sensitive molecular biology 
techniques will eventually facilitate the identification of oestrus specific genes and 
consequently any proteins encoded by them. 
 
Photo 1 Molecular approches that allow detailed analysis of protein and gene expression are 
rapidly expanding our understanding of reproductive processes 
Biosensor Approach: An alternative approach to automate the detection of oestrus is to 
use biosensor technology. A biosensor is a device designed to respond to the presence of a 
specific biochemical by emitting an electrical signal. A practical biosensor should be 
reusable and relatively inexpensive. An efficient immunologically based biosensor for 
progesterone in milk, is currently being developed in collaboration with the National 
Diagnostic Centre, NUI, Galway. The laboratory-based system currently being tested is 
capable of detecting the normal physiological changes in milk progesterone found during the 
bovine oestrous cycle. Such a biosensor would enable the in-line measurement of hormones 
on a daily basis during milking and provide valuable information to the herd owner regarding 
onset of oestrus and pregnancy status. 
Behavioural Approach: Heat detection is an even greater problem in beef cows as they are 
less likely to display oestrous activity while suckling, they are not usually heat checked as 
regularly as dairy cows and they are not milked. Biotechnology offers new approaches to the 
development of practical non-hormonal based methods of heat detection for use in the beef 
herd. The adaptation and modification of recent advances in computer-interfaced micro chip 
and telecommunication applications from industry, in conjunction with behavioural activity 
has led to the development of a number of potentially useful oestrous detection systems. 
These computer-based systems can be interrogated to determine the number of the animal 
in oestrus and the duration of oestrus and also provide information regarding the optimum 
time for insemination. One system, commercially available in the USA is currently being 
evaluated (Figure 1; HeatWatch®; DDX Inc., Colorado, USA). This system comprises a 
pressure sensitive battery-operated radio transmitter which is attached to the cows tail head 
using adhesive. When activated by a mounting cow, the transmitter emits a radio-signal 
which is picked up by a receiver located at the dairy. The signal is then digitised and stored 
on a computer together with the date and time, duration of each mount and the cows 
identity. This technology not only indicates when a cow is in standing estrus but also 
provides new information on the duration of heat and the interval from onset of heat to 
ovulation in heifers and cows under different environmental conditions (see Table 1). 
Currently the radio frequency that Heatwatch operates under is not available for commercial 
use in the EU. 
 
Figure 1 One of the most tedious, but also one of the more important factors affecting 
reproductive performance in both the dairy and beef herds is the efficiency of heat or oestrus 
detection. 
Other pressure sensor approaches include a system commercially available in Ireland (DEC, 
IMV, France). Similar in principle to the Heatwatch device, it is a pressure sensitive device 
attached to the cows tail head. This device records the elapsed time since the onset of 
standing oestrus by means of a flashing light. The device is calibrated so that the frequency 
of these flashes can be used to determine the elapsed time. 
Table 1. Duration of heat, number of mounts and interval from heat onset to ovulation in 
dairy cows and beef heifers 
  Animal 
Type 










Study 1 Beef Heifer 23 14.5±5.51 39±25.2 30.6±5.4 
Study 2 Beef Heifer 58 13.6±5.32 35±23.1 - 
Study 3 Dairy Cow 25 11.4±5.35 17.6±10.60 - 
5. Sexing of cattle sperm 
One area that has attracted significant research effort over the years is the possibility of 
developing technology that would allow sperm sexing in order to pre-determine the sex of 
the calf. The ability to pre-determine the sex of a calf, has been a long-standing goal of the 
dairy and beef industries world-wide and currently ranks as one of the most desirable 
reproductive technologies. An efficient and accurate system of sperm sexing combined with 
AI would have potential dramatic effects on the efficiency of milk and meat production. For 
example at present more than half the dairy herd must be bred to dairy bulls to provide a 
20% replacement rate. If heifer calves could be guaranteed from the use of sexed sperm 
less than one-third of the herd would have to be bred to dairy sires to provide replacements 
and up to 75% of the herd could be bred to beef bulls. The first major breakthrough in sperm 
sexing came from the discovery that female-determining sperm had 3-4% more DNA than 
male determining sperm. While this difference in DNA content is very small yet it was 
enough to develop a methodology to allow the separation into male determining or Y- 
chromosome bearing sperm and female or X-chromosome bearing sperm. Separation of bull 
sperm into X- and Y-chromosome-bearing cell fractions based on the difference in their DNA 
content relies on the use of a fluorescent dye that is taken up by the DNA. When illuminated 
with a laser light the fluorescent dye glows. Because the female determining sperm have 
more DNA they give off more light and can be separated from the male determining sperm 
using flow cytometry. The accuracy of this technique is high, and in initial trials well over 
90% of the calves born following the use of sexed sperm correspond to the predetermined or 
nominated sex. However, while accuracy is high, the laser light used reduces the viability of 
the sexed sperm and furthermore, the throughput is low. While sexed sperm is already being 
used in a limited number of in vitro embryo production studies, the high cost involved and the 
low throughput mean that sexed sperm produced by this technology is not yet available for 
widespread use in AI. This approach, based on DNA content requires a high degree of 
technical expertise and involves a number of distinct and modified procedures. 
 
Figure 2 Pre-determination of sperm sex has been a long term goal of the dairy and beef 
industries worldwide. Separation of bull sperm based on their DNA content, into male- and 
female- bearing fraction, has now been achieved with over 90% accuracy. 
The "new" science of proteomics however, offers an alternative approach to the 
development of a cost-effective and practical method of sperm sexing. Sex chromosome-
specific proteins (SCSPs) have been identified on the surface of sperm and this allows an 
immunological approach for sperm sexing to be developed that would be less invasive and 
less damaging to sperm (Fig. 3). In this approach, an antibody causes sperm of one sex to 
agglutinate or clump together. The free-swimming sperm of the opposite sex can easily be 
separated and processed for use in artificial insemination. 
 
Figure 3 Identification of sex chromosome- specific proteins (SCSPs) on the sperm surface 
would allow an immunological approach for sperm sexing that would be less invasive and 
less damaging to sperm. 
6. Embryo production and transfer technology 
Through semen collection, dilution and storage an AI bull can sire up to 100,000 calves in 
any one year, thus making a significant contribution to genetic improvement. In relative 
terms the genetic contribution of the cow, irrespective of her genetic value, is significantly 
less. Despite the fact that the ovaries of any cow contain tens of thousands of oocytes or 
immature ova each capable of being fertilised, nevertheless, each cow normally produces 
only a single calf per year, or an average of 4 to 5 calves in a lifetime. However, a range of 
embryo-based reproduction bio-technology procedures have been developed that allow a 
significant increase in the numbers of these oocytes that ovulate and can be fertilised and 
therefore in the number of calves that a cow can produce in one year. Superovulation and AI 
followed by embryo recovery and transfer allows the genetic contribution of outstanding 
cows to be increased. This embryo transfer technology has also contributed to the 
acceleration of genetic improvement by producing sires in multiple ovulation and embryo 
transfer (MOET) programmes. Furthermore, embryos are an excellent way of moving 
germplasm from one region to another without introducing new diseases. 
 
 Photo 2 Embryo based reproduction biotechnologies have been developed that significantly 
increase the contribution of the female to genetic improvement programmes 
Arising out of a range of developments in cattle embryo production and transfer, one of the 
studies undertaken was a field scale evaluation of the efficiency of the non-surgical transfer 
of laboratory produced or in vitro fertilised embryos. This field study was carried out by 
Ovamass Ltd, the commercial AI service and Teagasc. 
The objective was to carry out a field-scale test to examine cow reproductive efficiency and 
calf output, following the non-surgical transfer of in vitro fertilised (IVF) cattle embryos of 
continental breed types. The technology involved a simple in-straw freezing and thawing 
procedure and non-surgical transfer. This pre-commercial field test of the technology in Irish 
herds used the distribution network of the commercial AI stations. Operators from all the AI 
centres were trained in embryo thawing and non-surgical transfer. 
Two thousand IVF embryos of 3/4 to 7/8th continental breed type were produced and frozen-
stored in liquid nitrogen (-196°C) by the commercial partner in the project, Ovamass Ltd. A 
total of 3,435 cows on 570 farms were included in the study. All of the cows were artificially 
inseminated. Of these, 1,382 also received an IVF embryo transferred one week after 
breeding by a trained AI technician. Cows which were inseminated only (2,053) acted as 
contemporary controls. 
The majority of responding farmers (93%) kept accurate calving dates and 63% reported calf 
birth weights. Of the 570 herds involved, full information was retrieved from 390 (88%). 
Calving information was retrieved for 2376 (69%) of the cows in the study. Information was 
less forthcoming about suckler cows than dairy cows, a consequence of the fact that dairy 
farmers keep better records than beef farmers. Calving rate to a single breeding was similar 
for the ET and control cows (55% vs 56%). Data on calf output are shown in Table 2 for 
cows that calved. 
Table 2. Effect of an embryo transfer one week after AI on calf output 
  ET CONTROL P 
No. Cows 469 858   
Calves born per 
cow 
1.35 1.02 P<0.001 
Calves alive at 48 
h per cow 
1.25 0.99 P<0.001 
% multiple births 34% 2% P<0.001 
ET = AI followed by an embryo transfer; Control = AI only 
Of cows that calved and which had received an embryo, 34% had twin calves. The embryo 
transfer calves were normal in every respect. Calf production was increased in gross terms 
by 32% per cow following AI + ET, with 34% of term-calving ET cows giving birth to twin 
calves. When losses at calving were taken into account, ET increased live calf production by 
26%. 
Previous studies had documented the differences between single and twin calvings in terms 
of reduced gestation length, calf birth weight, increased dystocia, calf mortality and retention 
of the foetal membranes This study confirmed these findings. Calves produced from the 
transferred continental embryos were heavier and graded a better quality than those 
produced from AI. This improvement in calf quality was particularly significant with dairy 
breed recipients. Overall, 55% of the calves were bulls and 45% were heifers in this study, 
but there was no evidence of any bias within the ET calves. In addition, there were no 
reports of abnormalities in the ET calves. Other than calf quality, there were no features to 
distinguish calves derived from an IVF embryo from those produced by AI. The commercial 
AI service successfully delivered the embryo transfer service. 
7. Cryopreservation of embryos 
Many of the worlds rare breeds of cattle are facing extinction and with them a valuable 
genetic resource. The ability to cryopreserve germplasm banks of frozen embryos 
indefinitely allows genetic diversity to be preserved. Cattle embryos can now be successfully 
frozen and stored indefinitely at -196°C in liquid nitrogen. Cryopreservation is a multistage 
process incorporating a cryoprotectant or antifreeze and the thawing and transfer of embryos 
is carried out in a manner similar to frozen-thawed semen. Following freezing and thawing 
pregnancy rates of up to 45% are currently achievable. 
In contrast to embryos, oocytes are extremely sensitive to chilling and are difficult to 
cryopreserve. The development of new cooling technologies using liquid nitrogen (LN2) 
cooled below -196°C (LN2 slush), however, have enabled the efficient cryopreservation of 
oocytes. In the future the cryopreservation of ovarian tissue will also become a reality 
enabling the preservation of pure genetic stocks of female as well as male gametes. 
8. Determining the sex of cattle embryos 
Like sperm sexing, the ability to determine the sex of an embryo prior to transfer, has been 
an objective of dairy and cattle breeders since the commercialisation of embryo transfer 
technology in the mid-seventies. The synthesis of a male determining or Y chromosome 
specific molecular probe, followed by the development of the polymerase chain reaction 
(PCR), used to amplify DNA, has enabled the practical application of this technique in the 
field, and is an excellent example of biotechnology transfer in animal breeding. At present 
only a few embryonic cells are required for the sexing procedure. In the future, 
immunological methods such as those being developed for sperm sexing will enable 
embryos to be sexed in a non-invasive fashion. Such methods will be technically simpler and 
more widely applicable. 
9. Producing embryos in the laboratory 
The last decade has seen a further significant breakthrough in terms of the production of 
cattle embryos by in vitro procedures. Knowledge of the fact that cow ovaries contain tens of 
thousands of oocytes or immature ova led to developments that allow large numbers of 
these oocytes to be harvested and then matured and fertilised in vitro. In humans this 
technique of in vitro fertilisation (IVF) and embryo transfer (ET), the so-called test tube baby 
technique, is one of the major assisted reproduction technologies (ART) now available to 
infertile couples today. The widespread uptake of human IVF technology by the medical field 
is largely due to the pioneering work carried out on cattle embryos over the last 30 years. 
Research into IVF in cattle has largely been carried out on oocytes recovered from 
slaughterhouse material, however, in this situation the donors have usually very little to offer 
in terms of genetic superiority. The use of ultrasonography now allows the immature oocytes 
to be collected in the live cow. This process called transvaginal ovum pick-up or OPU now 
allows oocytes to be harvested from animals of high genetic merit as often as twice weekly 
and over several months. Frequent collections means that following IVF a donor cow can 
potentially produce 50 to 100 pregnancies in one year, significantly increasing the female 
contribution to genetic improvement programmes. 
10. Embryo research and reproductive wastage in cattle 
While there is significant potential for developments in embryo-based biotechnology to 
increase the efficiency of animal agriculture, embryo mortality, nevertheless, remains the 
biggest reproductive block to efficiency. Following fertilisation, approximately 40% of cattle 
embryos die in vivo. Some of the information arising from embryo research programmes is 
now beginning to unravel the problem. For example we are now beginning to understand the 
basic biological mechanisms that govern embryo development and viability. Over the past 5 
years collaborative EU funded research programmes in this area have elucidated 
parameters such as cattle embryo growth rate, protein content protein synthesis patterns, 
signal transduction systems, gene and protein expression patterns and how these 
mechanisms are affected by factors such as animal nutrition. Such information is essential 
not only for the further development of embryo related biotechnology but will help to reduce 
the significant reproductive wastage that currently exists. 
Results previously published from this and other research programmes suggest that the 
period of greatest embryo loss occurs between 8 and 16 days after fertilisation. During this 
time the cattle embryo undergoes an exponential increase in size and protein content (Fig. 
4) as well as changes that facilitate the establishment of communication between the 
embryo and the uterus. For example, this communication between the embryo and the dam 
results in the synthesis and phosphorylation of proteins by the uterine epithelium, necessary 
for embryo development and the synthesis and phosphorylation of proteins by the embryo, 
necessary for the maternal recognition of pregnancy. The results indicate that following 
blastocyst formation at around day 8, metabolism in cattle embryos increases dramatically. 
By the time cattle blastocysts have begun to elongate around day 13, however, they have 
passed the period of greatest synthetic activity. 
 
Figure 4 Cattle embryos undergo an exponential increase in size and protein content from 
days 1-8 through to day 16 after fertilisation. 
Because of this high rate of metabolic activity between days 8 and 13 it is likely that 
blastocysts are very susceptible to environmental changes during this time that have the 
potential to interfere with normal development mechanisms. These results suggest that the 
critical period of early embryo loss in cattle may now be narrowed to a time window of day 8 
to 14 rather than day 8 to 16 as presumed up to now. 
11. Cloning 
The "cloning" of farm animals in recent times has engendered or indeed provoked many 
arguments in relation to food safety and therefore human safety and in relation to the ethical 
aspects of such developments. Indeed, the issue of cloning raises a number of possibilities, 
which range from the exciting to the unsettling. Like many aspects of biotechnology, cloning 
of course is not new. Identical human and animal twins happen regularly in nature and this is 
the simplest form of cloning. The birth of Dolly the sheep in 1996 of course fundamentally 
changed our understanding of the cell cycle and physiological processes occurring in 
embryos. Dolly was created from the nucleus of an adult mammary or differentiated cell. It 
had previously been thought that adult cells could not be reprogrammed back to an 
undifferentiated state. This breakthrough was subsequently repeated in cattle when calves 
were cloned from a skin cell. While this technology is still in its infancy and inefficient it does 
demonstrate the future possibilities for cloning elite or endangered animals without recourse 
to embryo or oocyte recovery per se. 
12. Biopharming 
Many of the products used in human disease control and therapeutic procedures, such as 
insulin, blood coagulation factor VIII and IX, growth hormone and albumin have been 
isolated as human and animal blood or tissue by-products. Some of these products have 
been in very short supply and only available at high cost or for a limited number of treatment 
cases. The use of human and animal by-products has also been associated with the 
transmission of highly infectious and sometimes fatal diseases. Genetic engineering, 
however, has made it possible to transfer or insert for example the gene responsible for 
human blood clotting factor VIII into bacteria which has enabled its relatively large scale 
production and wider availability. Despite these improvements, start-up and production costs 
of fermentation plants are high, and their use is limited to products where therapeutic doses 
are in the low milligram range or less. Additionally, bacteria often lack the cellular machinery 
required to produce and post translationally modify proteins sufficiently to be of therapeutic 
value. These proteins must be harvested from animal tissue. An alternative to bacterial 
production systems is insertion of the gene into an existing production system such as the 
mammary gland of the cow and harvesting the desired protein from the milk. This is now 
usually termed "biopharming". The potential for biopharming is enormous in that 10-100 
cows would be sufficient to satisfy current world demands for many pharmaceutical proteins, 
while production costs are estimated to be a tiny fraction of current industrial systems. While 
the initial application of biopharming will be to produce pharmaceutical proteins, more wide 
scale applications could include the production of nutriceuticals or orally taken proteins 
having both nutritional and therapeutic value. Further applications include specific antibody 
production in milk to confer increased immunity to newborn calves and the production of 
cows with resistance to diseases such as BSE. 
13. Acceptance of biotechnology developments 
While the huge economic and social potential of biotechnology is clear to scientists involved, 
the public is not yet convinced. Any public discussion on biotechnology to date has 
concentrated on alleged concerns of long-term effects of genetically modified organisms 
(GMOs) on human health and the environment. However, the potential benefits of 
biotechnology in cattle reproduction as indicated here need to be pointed out in order that 
informed decisions can be made by consumers on the question of biotechnology 
developments and their acceptability. 
Clearly scientists have immense responsibility in this whole area of animal biotechnology 
research. This responsibility is both to the animals and the public. It is in the common good 
that the boundaries of ignorance be pushed back but this must be done with regard to, and 
in the context of, good animal welfare. Also, the public must be kept informed of the purpose 
of and the developments arising from such research. In the future scientists must become 
more involved in the public debate. 
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